Mucoadhesive formulation of Bidens pilosa L. (Asteraceae) reduces intestinal injury from 5-fluorouracil-induced mucositis in mice

Toxicology Reports

Volumn 2, Issue , 2015, Pages 563-573

  de Ávila, Paulo Henrique Marcelino ^a   de Ávila, Renato Ivan ^a   dos Santos Filho, Edvande Xavier ^a   Cunha Bastos, Carla Caroline ^a   Batista, Aline Carvalho ^a   Mendonça, Elismauro Francisco ^a   Serpa, Raphael Caixeta ^a   Marreto, Ricardo Neves ^a   da Cruz, Andrezza Furquim ^a   Lima, Eliana Martins ^a   Valadares, Marize Campos ^a  

^a FEDERAL UNIVERSITY OF GOIÁS   (Brazil)

Author keywords

5 Fluorouracil; Bidens pilosa L. (Asteraceae); Chemotherapy; Intestinal injury; Mucoadhesive formulation; Mucositis

Indexed keywords

BIDENS PILOSA EXTRACT; FLUOROURACIL; KI 67 ANTIGEN; MALONALDEHYDE; MYELOPEROXIDASE; PLANT EXTRACT; POLOXAMER; PROTEIN BAX; PROTEIN BCL 2; PROTEIN P53;

ANIMAL EXPERIMENT; ANIMAL MODEL; ANIMAL TISSUE; ANTIINFLAMMATORY ACTIVITY; ARTICLE; BODY WEIGHT; CONTROLLED STUDY; DRUG DELIVERY SYSTEM; DRUG EFFICACY; DRUG MECHANISM; DRUG SAFETY; ENZYME ACTIVITY; HISTOPATHOLOGY; IMMUNOHISTOCHEMISTRY; INTESTINE FUNCTION; INTESTINE INJURY; LIPID PEROXIDATION; MALE; MORPHOMETRICS; MOUSE; MUCOADHESIVE DRUG DELIVERY SYSTEM; MUCOSA INFLAMMATION; NONHUMAN; PROTEIN EXPRESSION;

EID: 84927555883     PISSN: 22147500     EISSN: None     Source Type: Journal    
DOI: 10.1016/j.toxrep.2015.03.003     Document Type: Article

References (68)

1. Yeoh A.S.J., Gibson R.J., Yeoh E.E.K., Bowen J.M., Stringer A.M., Giam K.A., Keefe D.M.K. A novel animal model to investigate fractionated radiotherapy-induced alimentary mucositis: the role of apoptosis, p53, nuclear factor-κB, COX-1, and COX-2. Mol. Cancer Ther. 2007, 6:2319-2327.
2. Han X., Wu Z., Di J., Pan Y., Zhang H., Du Y., Cheng Z., Jin Z., Wang Z., Zheng Q., Zhang P., Wang Y. CXCL9 attenuated chemotherapy-induced intestinal mucositis by inhibiting proliferation and reducing apoptosis. Biomed. Pharmacother. 2011, 65:547-554.
3. Touchefeu Y., Montassier E., Nieman K., Gastinne T., Potel G., Bruley des Varannes S., Le Vacon F., de La Cochetière M.F. Systematic review: the role of the gut microbiota in chemotherapy-or radiation-induced gastrointestinal mucositis - current evidence and potential clinical applications. Aliment. Pharmacol. Ther. 2014, 40:409-421.
4. Tooley K.L., Saxon B.R., Webster J., Zacharakis B., McNeil Y., Davidson G.P., Butler R.N. A novel non-invasive biomarker for assessment of small intestinal mucositis in children with cancer undergoing chemotherapy. Cancer Biol. Ther. 2006, 5:1275-1281.
5. Azevedo O.G., Oliveira R.A., Oliveira B., Zaja-Milatovic S., Araujo C.V., Wong D.V., Costa T.B., Lucena H.B., Lima-Junior R.C., Ribeiro R.A., Warren C.A., Lima A.A., Vitek M.P., Guerrant R.L., Oriá R.B. Apolipoprotein E COG 133 mimetic peptide improves 5-fluorouracil-induced intestinal mucositis. BMC Gastroenterol. 2012, 12:35.
6. Carneiro-Filho B.A., Lima I.P., Araujo D.H., Cavalcante M.C., Carvalho G.H., Brito G.A., Lima V., Monteiro S.M., Santos F.N., Ribeiro R.A., Lima A.A. Intestinal barrier function and secretion in methotrexate-induced rat intestinal mucositis. Dig. Dis. Sci. 2004, 49:65-72.
7. Keefe D.M. Gastrointestinal mucositis: a new biological model. Support. Care Cancer 2004, 12:6-9.
8. Lalla R.V., Schubert M.M., Bensadoun R.J., Keefe D. Anti-inflammatory agents in the management of alimentary mucositis. Support. Care Cancer 2006, 14:558-565.
9. Yang W.-C. Botanical, pharmacological, phytochemical, and toxicological aspects of the antidiabetic plant Bidens pilosa L. Evid. Based Complement. Alternat. Med. 2014, 2014:1-14.
10. Abajo C., Boffill M.A., del Campo J., Méndez M.A., González Y., Mitjans M., Vinardell M.P. In vitro study of the antioxidant and immunomodulatory activity of aqueous infusion of Bidens pilosa. J. Ethnopharmacol. 2004, 93:319-323.
11. Bartolome A.P., Villaseñor I.M., Yang W.C. Bidens pilosa L. (Asteraceae): botanical properties, traditional uses, phytochemistry, and pharmacology. Evid. Based Complement. Alternat. Med. 2013, 2013:1-51.
12. Borges C.C., Matos T.F., Moreira J., Rossato A.E., Zanette V.C., Amaral P.A. Bidens pilosa L. (Asteraceae): traditional use in a community of southern Brazil. Rev. Bras. Plantas Med. 2013, 15:34-40.
13. Costa R.J., Diniz A., Mantovani M.S., Jordão B.Q. In vitro study of mutagenic potential of Bidens pilosa Linné and Mikania glomerata Sprengel using the comet and micronucleus assays. J. Ethnopharmacol. 2008, 118:86-93.
14. Brandão M.G.L., Nery C.G.C., Mamão M.A.S., Krettli A.U. Two methoxylated flavone glycosides from Bidens pilosa. Phytochemistry 1998, 48:397-399.
15. Valdés H.A.L., Rego H.P.L. Bidens pilosa Linné. Ver. Cubana Plant. Med. 2001, 6:28-33.
16. Alvarez A., Pomar F., Sevilla M.A., Montero M.J. Gastric antisecretory and antiulcer activities of an ethanolic extract of Bidens pilosa L. var. radiata Schult. Bip. J. Ethnopharmacol. 1999, 67:333-340.
17. Tan P.V., Dimo T., Dongo E. Effects of methanol, cyclohexane and methylene chloride extracts of Bidens pilosa on various gastric ulcer models in rats. J. Ethnopharmacol. 2000, 73:415-421.
18. Chih H.W., Lin C.C., Tanga K.S. The hepatoprotective effects of Taiwan Folk Medicine Ham-Hong-Chho in rats. Am. J. Chin. Med. 1996, 24:231-240.
19. Yuan L.P., Chen F.H., Ling L., Dou P.F., Bo H., Zhong M.M., Xia L.J. Protective effects of total flavonoids of Bidens pilosa L. (TFB) on animal liver injury and liver fibrosis. J. Ethnopharmacol. 2008, 116:539-546.
20. Ubillas R.P., Mendez C.D., Jolad S.D., Luo J., King S.R., Carlson T.J., Fort D.M. Antihyperglycemic acetylenic glucosides from Bidens pilosa. Planta Med. 2000, 66:82-83.
21. Jäger A.K., Hutchings A., van Staden J. Screening of Zulu medicinal plants for prostaglandin-synthesis inhibitors. J. Ethnopharmacol. 1996, 52:95-100.
22. Pereira R.L.C., Ibrahim T., Lucchetti L., Silva A.J.R., Moraes V.L.G. Immunosuppressive and anti-inflammatory effects of methanolic extract and the polyacetylene isolated from Bidens pilosa L. Immunopharmacology 1999, 43:31-37.
23. Kviecinski M.R., Felipe K.B., Schoenfelder T., Wiese L.P.L., Rossi M.H., Gonçalez E., Felicio J.D., Filho D.W., Pedrosa R.C. Study of the antitumor potential of Bidens pilosa (Asteraceae) used in Brazilian folk medicine. J. Ethnopharmacol. 2008, 117:69-75.
24. Wu J., Wan Z., Yi J., Wu Y., Peng W., Wu J. Investigation of the extracts from Bidens pilosa Linn. var. radiata Sch. Bip. for antioxidant activities and cytotoxicity against human tumor cells. J. Nat. Med. 2013, 67:17-26.
25. Rabe T., van Staden J. Antibacterial activity of South African plants used for medicinal purposes. J. Ethnopharmacol. 1997, 56:81-87.
26. Dimo T., Rakotonirina S.V., Tan P.V., Azay J., Dongo E., Cros G. Leaf methanol extract of Bidens pilosa prevents and attenuates the hypertension induced by high-fructose diet in Wistar rats. J. Ethnopharmacol. 2002, 83:183-191.
27. Chiang Y.M., Chuang D.Y., Wang S.Y., Kuo Y.H., Tsai P.W., Shyur L.F. Metabolite profiling and chemopreventive bioactivity of plant extracts from Bidens pilosa. J. Ethnopharmacol. 2004, 95:409-419.
28. Brandão M.G.L., Krettli A.U., Soares L.S.R., Nery C.G.C., Marinuzzi H.C. Antimalarial activity of extracts and fractions from Bidens pilosa and other Bidens species (Asteraceae) correlated with the presence of acetylene and flavonoid compounds. J. Ethnopharmacol. 1997, 57:131-138.
29. Oliveira F.Q., Andrade-Neto V., Krettli A.U., Brandão M.G.L. New evidences of antimalarial activity of Bidens pilosa roots extract correlated with polyacetylene and flavonoids. J. Ethnopharmacol. 2004, 93:39-42.
30. Chiang Y.M., Chang C.L.T., Chang S.L., Yang W.C., Shyur L.F. Cytopiloyne, a novel polyacetylenic glucoside from Bidens pilosa, functions as a T helper cell modulator. J. Ethnopharmacol. 2007, 110:532-538.
31. Silva F.L., Fischer D.C.H., Tavares J.F., Silva M.S., Athayde-Filho P.F., Barbosa-Filho J.M. Compilation of secondary metabolites from Bidens pilosa L. Molecules 2011, 16:1070-1102.
32. Varum F.J.O., McConnell E.L., Sousa J.J.S., Veiga F., Basit A.W. Mucoadhesion and the gastrointestinal tract. Crit. Rev. Ther. Drug Carr. Syst. 2008, 25:207-258.
33. Rossi S., Marciello M., Bonferoni M.C., Ferrari F., Sandri G., Dacarro C., Grisoli P., Caramella C. Thermally sensitive gels based on chitosan derivatives for the treatment of oral mucositis. Eur. J. Pharm. Biopharm. 2010, 74:248-254.
34. Desai K.G.H., Mallery S.R., Holpuch A.S., Schwenderman S.P. Development and in vitro-in vivo evaluation of fenretinide-loaded oral mucoadhesive patches for site-specific chemoprevention of oral cancer. Pharm. Res. 2011, 28:2599-2609.
35. Del Fante C., Perotti C., Bonferoni M.C., Rossi S., Sandri G., Ferrari F., Scudeller L., Caramella C.M. Platelet lysate mucohadesive formulation to treat oral mucositis in graft versus host disease patients: a new therapeutic approach. AAPS PharmSciTech 2011, 12:893-899.
36. Bautzová T., Rabišková M., Béduneau A., Pellequer Y., Lamprecht A. Bioadhesive pellets increase local 5-aminosalicylic acid concentrationin experimental colitis. Eur. J. Pharm. Biopharm. 2012, 81:379-385.
37. Ponchel G., Irache J. Specific and non-specific bioadhesive particulate systems for oral delivery to the gastrointestinal tract. Adv. Drug Deliv. Rev. 1998, 34:191-219.
38. Dumortier G., Grossiord J.L., Agnely F., Chaumeil J.C. A review of poloxamer 407 pharmaceutical and pharmacological characteristics. Pharm. Res. 2006, 23:2709-2728.
39. Swain T., Hillis W.E. The phenolic constituents of Prunus domestica. I. The quantitative analysis of phenolic constituents. J. Sci. Food Agric. 1999, 10:63-68.
40. Roesler R., Catharino R.R., Malta L.G., Eberlin M.N., Pastore G. Antioxidant activity of Caryocar brasiliense (pequi) and characterization of components by electrospray ionization mass spectrometry. Food Chem. 2008, 110:711-717.
41. Hubrecht R., Kirkwood J. The UFAW Handbook on the Care and Management of Laboratory and Other Research Animals 2010, Wiley-Blackwell, United Kingdom. 8th ed.
42. Wu Z., Han X., Qin S., Zheng Q., Wang Z., Xiang D., Zhang J., Lu H., Wu M., Zhu S., Yu Y., Han W. Interleukin 1 receptor antagonist reduces lethality and intestinal toxicity of 5-fluorouracil in a mouse mucositis model. Biomed. Pharmacother. 2010, 64:589-593.
43. Lima V., Brito G.A.C., Cunha F.Q., Rebouças C.G., Falcão B.A.A., Augusto R.F., Souza M.L.P., Leitão B.T., Ribeiro R.A. Effects of the tumour necrosis factor-α inhibitors pentoxifylline and thalidomide in short-term experimental oral mucositis in hamsters. Eur. J. Oral Sci. 2005, 113:210-217.
44. Wright T.H., Yazbeck R., Lymn K.A., Whitford E.J., Cheah K.Y., Butler R.N., Feinle-Bisset C., Pilichiewicz A.N., Mashtoub S., Howarth G.S. The herbal extract Iberogast® improves jejunal integrity in rats with 5-Fluorouracil (5-FU)-induced mucositis. Cancer Biol. Ther. 2009, 8:923-929.
45. Keefe D.M.K., Brealey J., Goland J.G., Cummins A.G. Chemotherapy for cancer causes apoptosis that precedes hypoplasia in crypts of the small intestine in humans. Gut 2000, 47:632-637.
46. Chang C.T., Ho T.Y., Lin H., Liang J.A., Huang H.C., Li C.C., Lo H.Y., Wu S.L., Huang Y.F., Hsiang C.Y. 5-Fluorouracil induced intestinal mucositis via nuclear factor-κB activation by transcriptomic analysis and in vivo bioluminescence imaging. PLoS ONE 2012, 7:e31808.
47. Keefe D.M.K. Intestinal mucositis: mechanisms and management. Curr. Opin. Oncol. 2007, 19:323-327.
48. Lee C.S., Ryan E.J., Doherty G.A. Gastro-intestinal toxicity of chemotherapeutics in colorectal cancer: the role of inflammation. World J. Gastroenterol. 2014, 20:3751-3761.
49. Shiota A., Hada T., Baba T., Sato M., Yamanaka-Okumura H., Yamamoto H., Taketani Y., Takeda E. Protective effects of glycoglycerolipids extracted from spinach on 5-fluorouracil induced intestinal mucosal injury. J. Med. Invest. 2010, 57:314-320.
50. Huang T.Y., Chu H.C., Lin Y.L., Ho W.H., Hou H.S., Chao Y.C., Liao C.L. Minocycline attenuates 5-fluorouracil-induced small intestinal mucositis in mouse model. Biochem. Biophys. Res. Commun. 2009, 389:634-639.
51. Cárdenas M.B., Álvarez C.S., Morgado E.B., Gutiérrez M.G., Monteagudo G.L., Suarez O.S. Toxicological evaluation of an infusion of Bidens pilosa. Pharmacologyonline 2006, 3:428-434.
52. Frida L., Rakotonirina S., Rakotonirina A., Savineau J.P. In vivo and in vitro effects of Bidens pilosa L. (Asteraceae) leaf aqueous and ethanol extracts on primed-oestrogenized rat uterine muscle. Afr. J. Tradit. Complement. Altern. Med. 2008, 5:79-91.
53. Ezeonwumelu J.O.C., Julius A.K., Muhoho C.N., Ajayi A.M., Oyewale A.A., Tanayen J.K., Balogun S.O., Ibrahim A., Adzu B., Adiukwu C.P., Oloro J., Kiplagat D.M., Goji A.D.T., Okoruwa A.G., Onchweri A.N., Reddy P.M.K. Biochemical and histological studies of aqueous extract of Bidens pilosa leaves from Ugandan rift valley in rats. Br. J. Pharmacol. Toxicol. 2011, 2:302-309.
54. Wyllie A.H. Where, O, death, is thy sting? A brief review of apoptosis biology. Mol. Neurobiol. 2010, 42:4-9.
55. Galluzzi L., Bravo-San Pedro J.M., Vitale I., Aaronson S.A., Abrams J.M., Adam D., Alnemri E.S., Andrews D., Annicchiarico-Petruzzelli M., Baehrecke E.H., Bazan N.G., Bertrand M.J., Bianchi K., Blagosklonny M.V., Blomgren K., Borner C., Bredesen D.E., Brenner C., Campanella M., Candi E., Cecconi F., Chan F.K., Chandel N.S., Cheng E.H., Chipuk J.E., Cidlowski J.A., Ciechanover A., Dawson T.M., Dawson V.L., De Laurenzi V., De Maria R., Debatin K.M., Di Daniele N., Dixit V.M., Dynlacht B.D., El-Deiry W.S., Fimia G.M., Flavell R.A., Fulda S., Garrido C., Gougeon M.L., Green D.R., Gronemeyer H., Hajnoczky G., Hardwick J.M., Hengartner M.O., Ichijo H., Joseph B., Jost P.J., Kaufmann T., Kepp O., Klionsky D.J., Knight R.A., Kumar S., Lemasters J.J., Levine B., Linkermann A., Lipton S.A., Lockshin R.A., López-Otín C., Lugli E., Madeo F., Malorni W., Marine J.C., Martin S.J., Martinou J.C., Medema J.P., Meier P., Melino S., Mizushima N., Moll U., Muñoz-Pinedo C., Nuñez G., Oberst A., Panaretakis T., Penninger J.M., Peter M.E., Piacentini M., Pinton P., Prehn J.H., Puthalakath H., Rabinovich G.A., Ravichandran K.S., Rizzuto R., Rodrigues C.M., Rubinsztein D.C., Rudel T., Shi Y., Simon H.U., Stockwell B.R., Szabadkai G., Tait S.W., Tang H.L., Tavernarakis N., Tsujimoto Y., Vanden Berghe T., Vandenabeele P., Villunger A., Wagner E.F., Walczak H., White E., Wood W.G., Yuan J., Zakeri Z., Zhivotovsky B., Melino G., Kroemer G. Essential versus accessory aspects of cell death: recommendations of the NCCD 2015. Cell Death Differ. 2015, 22:58-73.
56. Wong R.S.Y. Apoptosis in cancer: from pathogenesis to treatment. J. Exp. Clin. Cancer Res. 2011, 30:87.
57. Andersen J.L., Kornbluth S. The tangled circuitry of metabolism and apoptosis. Mol. Cell 2013, 49:399-410.
58. Sonis S.T., Elting L.S., Keefe D., Peterson D.E., Schubert M., Hauer-Jensen M., Bekele B.N., Raber-Durlacher J., Donnelly J.P., Rubenstein E.B. Perspectives on cancer therapy-induced mucosal injury: pathogenesis, measurement, epidemiology, and consequences for patients. Cancer 2004, 100:1995-2025.
59. Bowen J.M., Gibson R.J., Cummins A.G., Keefe D.M.K. Intestinal mucositis: the role of the Bcl-2 family, p53 and caspases in chemotherapy-induced damage. Support. Care Cancer 2006, 14:713-731.
60. Kanarek N., Grivennikov S.I., Leshets M., Lasry A., Alkalay I., Horwitz E., Shaul Y.D., Stachler M., Voronov E., Apte R.N., Pagano M., Pikarsky E., Karin M., Ghosh S., Ben-Neriah Y. Critical role for IL-1β in DNA damage-induced mucositis. Proc. Natl. Acad. Sci. U. S. A. 2014, 111:E702-E711.
61. Gudkov A.V., Gurova K.V., Komarova E.A. Inflammation and p53: a tale of two stresses. Genes Cancer 2011, 2:503-516.
62. Dowsett M., Nielsen T.O., A'Hern R., Bartlett J., Coombes R.C., Cuzick J., Ellis M., Henry N.L., Hugh J.C., Lively T., McShane L., Paik S., Penault-Llorca F., Prudkin L., Regan M., Salter J., Sotiriou C., Smith I.E., Viale G., Zujewski J.A., Hayes D.F. Assessment of Ki67 in breast cancer: recommendations from the international Ki67 in breast cancer working group. J. Natl. Cancer Inst. 2011, 103:1656-1664.
63. Reaves T.A., Chin A.C., Parkos C.A. Neutrophil transepithelial migration: role of toll-like receptors in mucosal inflammation. Mem. Inst. Oswaldo Cruz 2005, 100:191-198.
64. Deng J.S., Chi C.S., Huang S.S., Shie P.H., Lin T.H., Huang G.J. Antioxidant, analgesic, and anti-inflammatory activities of the ethanolic extracts of Taxillus liquidambaricola. J. Ethnopharmacol. 2011, 137:1161-1171.
65. Cheah K.Y., Howarth G.S., Yazbeck R., Wright T.H., Whitford E.J., Payne C., Butler R.N., Bastian S.E.P. Grape seed extract protects IEC-6 cells from chemotherapy-induced cytotoxicity and improves parameters of small intestinal mucositis in rats with experimentally-induced mucositis. Cancer Biol. Ther. 2009, 8:382-390.
66. Gulgun M., Erdem O., Oztas E., Kesik V., Balamtekin N., Vurucu S., Kul M., Kismet E., Koseoglu V. Proanthocyanidin prevents methotrexate-induced intestinal damage and oxidative stress. Exp. Toxicol. Pathol. 2010, 62:109-115.
67. Kolli V.K., Abraham P., Isaac B., Kasthuri N. Preclinical efficacy of melatonin to reduce methotrexate-induced oxidative stress and small intestinal damage in rats. Dig. Dis. Sci. 2013, 58:959-969.
68. Yang H.L., Chen S.C., Chang N.W., Chang J.M., Lee M.L., Tsai P.C., Fu H.H., Kao W.W., Chiang H.C., Wang H.H., Hseu Y.C. Protection from oxidative damage using Bidens pilosa extracts in normal human erythrocytes. Food Chem. Toxicol. 2006, 44:1513-1521.